Group Leader
Jordi Barquinero Mañez
Principal Investigator (PI)
Jordi Barquinero Máñez
PhD Students
Rocío Piñera Moreno, Penélope Romero Duque, María Gallego Rodríguez (Master TFM student)
2
PUBLICATIONS
50.0%
%Q1
12
IMPACT FACTOR
6.14
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Galiñanes M, Casós K, Blasco-Lucas A, Permanyer E, Máñez R, Le Tourneau T, Barquinero J, Schwartz S Jr, Roussel TBJC, Fellah-Hebia I, Sénage T, Evangelista A, Badano LP, Ruiz-Majoral A, Galli C, Padler-Karavani V, Soulillou JP, Vidal X, Cozzi E, Costa C.
Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical Study
Biomolecules. 2022 Oct 31;12(11):1606
DOI: doi: 10.3390/biom12111606
IF: 6.064
Cuenca S, Soler Z, Serrano-Gómez G, Xie Z, Barquinero J, Roca J, Sirvent JM, Manichanh C
Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients
Int J Mol Sci. 2022 Dec 13;23(24):15808
DOI: doi: 10.3390/ijms232415808
IF: 6.208
Development of a novel gene therapy strategy and clinical trial readiness of a cohort of patients with merosin-deficient congenital muscular dystrophy
Principal Investigator: Jordi Barquinero / Francina Munell
Agency: Instituto de Salud Carlos III
Funding: 139,915 €
Period: 2020-2022